KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Total Liabilities (2016 - 2026)

Zimmer Biomet Holdings has reported Total Liabilities over the past 18 years, most recently at $10.0 billion for Q1 2026.

  • For Q1 2026, Total Liabilities rose 2.66% year-over-year to $10.0 billion; the TTM value through Mar 2026 reached $10.0 billion, up 2.66%, while the annual FY2025 figure was $10.4 billion, 16.84% up from the prior year.
  • Total Liabilities for Q1 2026 was $10.0 billion at Zimmer Biomet Holdings, down from $10.4 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $10.7 billion in Q3 2025 and troughed at $8.7 billion in Q3 2023.
  • A 5-year average of $9.4 billion and a median of $9.1 billion in 2023 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: dropped 19.86% in 2022 and later rose 17.79% in 2025.
  • Year by year, Total Liabilities stood at $9.0 billion in 2022, then dropped by 0.34% to $9.0 billion in 2023, then decreased by 1.33% to $8.9 billion in 2024, then increased by 16.84% to $10.4 billion in 2025, then decreased by 3.33% to $10.0 billion in 2026.
  • Business Quant data shows Total Liabilities for ZBH at $10.0 billion in Q1 2026, $10.4 billion in Q4 2025, and $10.7 billion in Q3 2025.